Literature DB >> 21414393

Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics.

Tingting Guan1, Yuqiang Miao, Lishuang Xu, Shenshen Yang, Jing Wang, Haibing He, Xing Tang, Cuifang Cai, Hui Xu.   

Abstract

The main purpose of this study was to prepare nimodipine-loaded nanoliposomes for injection and evaluate their characteristics after lyophilization. Nimodipine-loaded nanoliposomes were prepared by the emulsion-ultrasonic method with sodium cholesterol sulfate (SCS) as the regulator and then lyophilized by adding different cryoprotectants. SCS was used as a blender of regulator and surfactant and helped to prepare smaller liposomes due to the steric hindrance of the sulfate group. The results showed that nimodipine-loaded nanoliposomes with a 20:1 of egg yolk lecithin PL-100M vs. SCS ratio had a particle size of 86.8±42.007 nm, a zeta potential of -13.94 mV and an entrapment efficiency (EE) of 94.34% and could be stored for 12 days at 25°C. Because of the good bulking effect of mannitol and the preservative effect of trehalose, they were used to obtain suitable lyophilized nanoliposomes. The lyophiles containing 10% mannitol and 20% trehalose had a good appearance and a slightly altered particle size after rehydration. In addition, the lyophilized products were characterized by differential scanning calorimetry, X-ray diffraction and scanning electron microscopy, which confirmed the morphous state of trehalose, mannitol and the mixture. Trehalose could inhibit mannitol crystallization to some extent. The drug release from nanoliposomes before and after lyophilization in pH 7.4 phosphate buffer containing 30% ethanol was also examined and both profiles were found to fit the Viswanathan equation. This means that the drug release was controlled by the pore diffusion resistance.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414393     DOI: 10.1016/j.ijpharm.2011.03.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Sustained Release of Green Tea Polyphenols from Liposomal Nanoparticles; Release Kinetics and Mathematical Modelling.

Authors:  Ravi Theaj Prakash Upputuri; Abul Kalam Azad Mandal
Journal:  Iran J Biotechnol       Date:  2017-12-29       Impact factor: 1.671

2.  Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.

Authors:  Yingyue Zhang; Jie Feng; Simon A McManus; Hoang D Lu; Kurt D Ristroph; Eugene J Cho; Ellen L Dobrijevic; Hak-Kim Chan; Robert K Prud'homme
Journal:  Mol Pharm       Date:  2017-09-20       Impact factor: 4.939

3.  Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.

Authors:  Zaijin Teng; Miao Yu; Yang Ding; Huaqing Zhang; Yan Shen; Menglao Jiang; Peixin Liu; Yaw Opoku-Damoah; Thomas J Webster; Jianping Zhou
Journal:  Int J Nanomedicine       Date:  2018-12-21

4.  Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.

Authors:  Jingjing Li; Kai Zhang; Di Wu; Lianjie Ren; Xinyu Chu; Chao Qin; Xiaopeng Han; Taijun Hang; Yungen Xu; Lei Yang; Lifang Yin
Journal:  Asian J Pharm Sci       Date:  2021-10-21       Impact factor: 6.598

5.  A Novel Drug Delivery Carrier Comprised of Nimodipine Drug Solution and a Nanoemulsion: Preparation, Characterization, in vitro, and in vivo Studies.

Authors:  Saixu Huang; Zhiyong Huang; Zhiqin Fu; Yamin Shi; Qi Dai; Shuyan Tang; Yongwei Gu; Youfa Xu; Jianming Chen; Xin Wu; Fuzheng Ren
Journal:  Int J Nanomedicine       Date:  2020-02-18

6.  Preparation and Characterization of Novel Perfluorooctyl Bromide Nanoparticle as Ultrasound Contrast Agent via Layer-by-Layer Self-Assembly for Folate-Receptor-Mediated Tumor Imaging.

Authors:  Yue Hu; Yong Wang; Jianshuai Jiang; Baosan Han; Shengmin Zhang; Keshi Li; ShuXiong Ge; Yahui Liu
Journal:  Biomed Res Int       Date:  2016-08-29       Impact factor: 3.411

7.  A quality by design approach for the development of lyophilized liposomes with simvastatin.

Authors:  Alina Porfire; Dana Maria Muntean; Lucia Rus; Bianca Sylvester; Ioan Tomuţă
Journal:  Saudi Pharm J       Date:  2017-02-09       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.